Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02815592
Title Trial of BMS-986012 in Combination With Platinum and Etoposide
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung small cell carcinoma

Therapies

Etoposide

BMS-986012 + Cisplatin + Etoposide

BMS-986012 + Carboplatin + Etoposide

Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.